HB Wealth Management LLC Increases Position in CME Group Inc. (NASDAQ:CME)

HB Wealth Management LLC grew its stake in CME Group Inc. (NASDAQ:CME) by 17.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,736 shares of the financial services provider’s stock after acquiring an additional 1,175 shares during the quarter. HB Wealth Management LLC’s holdings in CME Group were worth $2,052,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Wayfinding Financial LLC acquired a new stake in shares of CME Group in the 1st quarter worth $25,000. Cornerstone Planning Group LLC boosted its position in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 55 shares in the last quarter. New Age Alpha Advisors LLC boosted its position in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 43 shares in the last quarter. Golden State Wealth Management LLC boosted its position in shares of CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Finally, Alpine Bank Wealth Management acquired a new stake in shares of CME Group in the 1st quarter worth $32,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Performance

NASDAQ CME opened at $274.12 on Tuesday. The stock has a 50-day simple moving average of $276.36 and a two-hundred day simple moving average of $263.03. The firm has a market capitalization of $98.78 billion, a P/E ratio of 26.54, a PEG ratio of 4.96 and a beta of 0.44. CME Group Inc. has a fifty-two week low of $193.25 and a fifty-two week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The company’s revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the business posted $2.56 EPS. On average, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.82%. CME Group’s payout ratio is currently 48.40%.

Insider Buying and Selling at CME Group

In related news, insider Derek Sammann sold 4,650 shares of CME Group stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $280.61, for a total value of $1,304,836.50. Following the completion of the transaction, the insider owned 8,336 shares in the company, valued at $2,339,164.96. The trade was a 35.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Phyllis M. Lockett sold 1,060 shares of CME Group stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the transaction, the director owned 3,108 shares of the company’s stock, valued at approximately $863,651.04. This represents a 25.43% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,400 shares of company stock worth $2,881,130. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on CME shares. Morgan Stanley raised their price objective on CME Group from $301.00 to $304.00 and gave the stock an “overweight” rating in a research report on Thursday, April 24th. JPMorgan Chase & Co. lowered their price objective on CME Group from $223.00 to $211.00 and set an “underweight” rating for the company in a research report on Thursday, April 24th. Barclays set a $298.00 price target on CME Group and gave the stock an “equal weight” rating in a research report on Thursday, July 24th. Keefe, Bruyette & Woods lifted their price target on CME Group from $265.00 to $273.00 and gave the stock a “market perform” rating in a research report on Thursday, April 24th. Finally, UBS Group reaffirmed a “neutral” rating and set a $305.00 price target on shares of CME Group in a research report on Thursday, July 24th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $261.93.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.